BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9725812)

  • 1. Impaired phasic insulin and amylin secretion in diabetic rats.
    Leahy JL; Fineman MS
    Am J Physiol; 1998 Sep; 275(3):E457-62. PubMed ID: 9725812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats.
    Hosokawa YA; Leahy JL
    Diabetes; 1997 May; 46(5):808-13. PubMed ID: 9133548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents.
    Moore CX; Cooper GJ
    Biochem Biophys Res Commun; 1991 Aug; 179(1):1-9. PubMed ID: 1679326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
    Leahy JL; Bumbalo LM; Chen C
    Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
    Hosokawa YA; Hosokawa H; Chen C; Leahy JL
    J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats.
    Gedulin B; Cooper GJ; Young AA
    Biochem Biophys Res Commun; 1991 Oct; 180(2):782-9. PubMed ID: 1953751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of amylin from perfused rat pancreas in response to glucose, arginine, beta-hydroxybutyrate, and gliclazide.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Diabetes; 1991 Aug; 40(8):1005-9. PubMed ID: 1860552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas.
    Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1993 Mar; 25(3):135-7. PubMed ID: 8477949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.
    Leahy JL; Bonner-Weir S; Weir GC
    Diabetes; 1984 Jul; 33(7):667-73. PubMed ID: 6203798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of amylin (islet amyloid polypeptide) on insulin response to non-glucose stimuli. Study in perfused rat pancreas.
    Salas M; Silvestre RA; Garcia-Hermida O; Fontela T; Rodriguez-Gallardo J; Marco J
    Diabete Metab; 1995 Oct; 21(4):269-73. PubMed ID: 8529762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level.
    Leahy JL; Weir GC
    Diabetologia; 1991 Sep; 34(9):640-7. PubMed ID: 1955096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disparity between the effect of glucose and arginine on insulin secretion from the perfused pancreas of non insulin dependent diabetic rats].
    Giroix MH; Portha B; Kergoat M; Picon L
    C R Seances Acad Sci III; 1981 Nov; 293(10):601-6. PubMed ID: 6800578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats.
    Inoue Y; Tanigawa K; Nakamura S; Xu G; Kawaguchi M; Kato Y; Tamura K
    Diabetes Res Clin Pract; 1995 Jan; 27(1):19-26. PubMed ID: 7781490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central visfatin potentiates glucose-stimulated insulin secretion and β-cell mass without increasing serum visfatin levels in diabetic rats.
    Kim DS; Kang S; Moon NR; Park S
    Cytokine; 2014 Feb; 65(2):159-66. PubMed ID: 24332931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated hexokinase activity in isolated islets from diabetic 90% pancreatectomized rats.
    Hosokawa H; Hosokawa YA; Leahy JL
    Diabetes; 1995 Nov; 44(11):1328-33. PubMed ID: 7589832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.
    Novelli M; Pocai A; Lajoix AD; Beffy P; Bezzi D; Marchetti P; Gross R; Masiello P
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):77-82. PubMed ID: 15149729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin tonally regulates arginine-stimulated insulin secretion in rats.
    Bennet WM; Beis CS; Ghatei MA; Byfield PG; Bloom SR
    Diabetologia; 1994 Apr; 37(4):436-8. PubMed ID: 8063047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia.
    Liu YQ; Nevin PW; Leahy JL
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E68-73. PubMed ID: 10893324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.